| |
 
About Novopower

NOVOPOWERis a direct compression excipient that can be used directly by mixing with API for compressing tablets. It is designed, developed and manufactured in FDA approved facility under strict supervision of our scientist team.

NOVOPOWER is consisted of all ingredients those are required for granulation except API which includes diluents/bulking agents, binders, anti adherents, disintegrate, lubricants as per the need and properties of the API for formulation.

NOVOPOWER is consisted of all ingredients those are required for granulation except API which includes diluents/bulking agents, binders, anti adherents, disintegrate, lubricants as per the need and properties of the API for formulation.

NOVOPOWER has excellent flow-ability and compressibility, uniform particle size distribution and better dilution potential. 

Even for low dosage formulation, it gives excellent drug distributions if used in a geometrical proportion.

Use of NOVOPOWER leads to minimizing operational cost; like it eliminates wet granulation, drying, sifting, dry screening etc. 

Only final mixing with API is to be done and the product is ready for compression. So, it is one step operation to make granules ready for compression. It reduces man power, electricity and operation time per batch; saves energy in terms of drying and other granulation step and eliminates hazardous steps etc.

It has control moisture and heat free processing; hence can be used for moisture sensitive and thermolabile drugs successfully.

Yield can be improved as operations are minimized resulting into controlled losses.

NOVOPOWER can be made customized as per the need and requirement of API and customer respectively.

For formulating individual NOVOPOWER for a particular API, following parameters are taken into consideration:

» Nature of API - Amorphous / granular - hygroscopic, light sensitive. 
» Dose of API per tablet.
» Average weight of the tablet.
» Compatibility with excipients and physicochemical characteristics of API.
» Release Profile for Sustained Release Formulation.

Before compression at the customer’s end only API is added depending upon the compression facility / machine. Hence, NOVOPOWER is not a generalized product but specific Direct Compression Excipient that is formulated for specific API, which will have better performance and stability.

Depending upon the drug one can adjust the proportions in formulation to achieve best results.

 
 
copyright @ 2012 Novo All Rights Reserved. Disclaimer | Sitemap Credits
 
kate spade outlet Louis Vuitton Outlet kate spade outlet Wolf Grey 3s michael kors outlet sport blue 3s Michael Kors Outlet jordan 3 sport blue Cheap Oakley Sunglasses sport blue 3s jordan 6 sport blue sport blue 6s louis vuitton outlet kate spade outlet wolf grey 3s foamposites shooting stars sport blue 3s thunder 14s kate spade outlet foamposites